Hepatitis C virus seropositivity and TNF superfamily receptors: SCD40, sFas - The new putative determinants of endothelial dysfunction in haemodialysis patients

Thrombosis Research

Volumn 126, Issue 5, 2010, Pages 393-398

  Pawlak, Krystyna ^a   Mysliwiec, Michal ^a   Pawlak, Dariusz ^a,b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Anti HCV seropositivity; Endothelial dysfunction; Haemodialysis; SCD40; SFas

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INDEPENDENT VARIABLE; LIVER CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ANTIGENS, CD40; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FAS LIGAND PROTEIN; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RENAL DIALYSIS;

EID: 78149282884     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.07.023     Document Type: Article

References (30)

1. N. Ishizaka, Y. Ishizaka, E. Takahashi, E. Tooda, H. Hashimoto, and R. Nagai Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickness Lancet 359 2002 133 135
2. J.M. Hui, A. Sud, G.C. Farrell, P. Bandara, K. Byth, and J.G. Kench Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression Gastroenterol 125 2003 1695 1704
3. Y.M. Chung, K.J. Park, S.Y. Choi, S.B. Hwang, and S.Y. Lee Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway Biochem Biophys Res Commun 284 2001 15 19
4. A. Kulwas, A. Szaflarska-Szczepanik, M. Czerwionka-Szaflarska, and M. Kotschy Von Willebrand factor and thrombomodulin as markers of endothelial cell functions in children with chronic viral hepatitis Med Wieku Rozwoj 8 2004 107 114
5. M. Zeniya, H. Fukata, and G. Toda Thrombomodulin expression of sinusoidal endothelial cells in chronic viral hepatitis J Gastroenterol Hepatol 10 Suppl. 1 1995 S77 S80
6. G. Kaplanski, C. Farnarier, M.J. Payan, P. Bongrand, and J.M. Durand Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis Dig Dis Sci 42 1997 2277 2284
7. S.S. Yang, G. Tsai, C.H. Wu, and D.S. Chen Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis Hepatogastroenterology 43 1996 575 581
8. J. Borawski, B. Naumnik, K. Pawlak, and M. Mysliwiec Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients Nephrol Dial Transplant 16 2001 787 792
9. J. Borawski, B. Naumnik, and M. Mysliwiec Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy Clin Appl Thromb Hemost 8 2002 359 367
10. Y.-S. Peng, C.-K. Chiang, S.-P. Hsu, M.-F. Pai, K.-Y. Hung, and J.-H. Kao Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients Blood Purif 23 2005 106 112
11. R. Fischer, T. Baumert, and H.E. Blum Hepatitis C virus infection and apoptosis World J Gastroenterol 13 2007 4865 4872
12. E. Hatano Tumor necrosis factor signaling in hepatocyte apoptosis J Gastroenterol Hepatol 22 Suppl. 1 2007 S43 S44
13. S.C. Afford, S. Randhawa, A.G. Eliopoulos, S.G. Hubscher, L.S. Young, and D.H. Adams CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas mediated hepatocyte death during allograft rejection J Exp Med 189 1999 441 446
14. H. Schmilovitz-Weiss, A. Belinki, O. Pappo, J. Sulkes, E. Melzer, and E. Kaganovski Role of circulating soluble CD40 as an apoptotic marker in liver disease Apoptosis 9 2004 205 210
15. A.E. El Bassiouny, N.E. El- Bassiouni, M.M. Nosseir, M.M. Zoheiry, E.G. El-Ahwany, and F. Salah Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma Medscape J Med 10 2008 130
16. K. Pawlak, B. Naumnik, S. Brzosko, D. Pawlak, and M. Mysliwiec Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients Am J Nephrol 24 2004 154 161
17. A. Papagianni, E. Kokolina, M. Kalovoulos, D. Kirmiziz, A. Vainas, and A.-M. Belechri Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis Nephrol Dial Transplant 19 2004 1258 1263
18. R.F. Schwabe, H. Engelmann, S. Hess, and H. Fricke Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients Clin Exp Immunol 117 1999 153 158
19. M.C. Perianayagam, S.L. Murray, V.S. Balakrishnan, D. Guo, A.J. King, and J.G. Pereira Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure J Lab Clin Med 136 2000 320 327
20. P.-S. Lim, M.-Y. Wu, S.-W. Chien, T.-K. Wu, C.-S. Liu, and C.-Y. Hu Tsai Pai M-A. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease Nephrology 13 2008 677 683
21. M.J. Hebert, M. Masse, N. Vigneault, I. Sirois, S. Troyanov, and F. Madore Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease Am J Kidney Dis 38 2001 1271 1276
22. J. Borawski, B. Naumnik, K. Pawlak, and M. Mysliwiec Endothelial dysfunction marker von Willebrand factor antygen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute chase response Nephrol Dial Transplant 16 2001 1442 1447
23. Z.M. Ruggeri Von Willebrand factor, platelets and endothelial cell interaction J Thromb Haemost 1 2003 1335 1342
24. A. Balasubramanian, N. Munshi, M.J. Koziel, Z. Hu, T.J. Liang, and J.E. Groopman Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells J Gen Virol 86 2005 3291 3301
25. M. Zeremski, L.M. Petrovic, and A.H. Talal The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection J Viral Hepat 14 2007 675 678
26. D. Kotowicz, G.L. Dixon, N.J. Klein, M.J. Peters, and R.E. Callard Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocytes Immunology 100 2000 441 448
27. J.E. Cardier, T. Schulte, H. Kammer, J. Kwak, and M. Cardier Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells FASEB J 13 1999 1950 1960
28. M. Yamako-Toya, S. Yamaguchi, J. Nitobe, S. Abe, S. Inoue, and N. Nozaki Dual response to Fas ligation in human endothelial cells: apoptosis and induction of chemokines, interleukin-8 and monocyte chemoattractant protein-1 Coron Artery Dis 14 2003 89 94
29. K. Pawlak, K. Zolbach, J. Borawski, M. Mysliwiec, O. Kovalchuk, and L. Chyczewski Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system In haemodialysis patients Thromb Res 123 2008 166 170
30. K. Pawlak, D. Pawlak, and M. Mysliwiec Hepatitis intensified oxidative stress, MIP-1β and RANTES plasma levels in uraemic patients Cytokine 28 2004 197 204